• Blog
  • Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Report

    Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Report

    Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Report
    Report code - SRHL234 Delivery - 2 Weeks
    Get Free Sample |
    Play Audio
    Listen
    Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market, Dynamics, and Ma See more...

    Market Insights

    The Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market is expected to grow from USD xx million in 2020 to USD xx million by 2026 at a CAGR of over x% during the forecast period.

    Figure: Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size, 2020-2026 (USD Million)

    Postural-Orthostatic-Tachycardia-Syndrome-(POTS)-Treatment-Market-Forecast

    Wish to get a free sample report? Click here.

    What is Postural orthostatic tachycardia syndrome (POTS)?

    Postural orthostatic tachycardia syndrome (POTS) is defined as a syndrome of orthostatic intolerance. It results in a nervous system breakdown wherein a person has various symptoms such as dizziness, anxiety, tremors, and orthostatic intolerance. The heart rate of a person having POTS is 120 beats/minute and it increases by 30 beats/minute when the person moves to a standing position.

    Key Players

    Key players operating in the global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market are-

    • Pfizer Inc. (The U.S),
    • Sanofi S.A. (France),
    • Novartis International AG (Switzerland),
    • The Merck Group (Germany),
    • AstraZeneca plc (UK),
    • Bayer AG (Germany),
    • Daiichi Sankyo Company Limited (Japan),
    • Cigna (The U.S), and
    • HCA International Limited (UK).

    Market Dynamics

    The growth of the global postural orthostatic tachycardia syndrome (POTS) treatment market is primarily driven by rising awareness among consumers regarding orthostatic intolerance.

    • The market players are continuously emphasizing investing in research and development activity to understand the nature of symptoms and thus, develop drugs/solutions to treat orthostatic intolerance is expected to contribute to the market growth substantially.
    • The unavailability of specific treatment for postural orthostatic tachycardia syndrome is likely to pose a hindrance to the market growth during the review period.

    Segment Analysis

    Application Trends

    Based on application, the market has been segmented into hospitals, clinics, ambulatory surgical centres, and research institutes.

    The hospitals' segment accounted for the largest market share in 2020 and is expected to continue its dominance over the forecast period due to the availability of skilled staff and treatment facilities for postural orthostatic tachycardia syndrome in hospitals.

    Regional Trends

    Geographically, the market in North America accounted for the largest market share in 2020. The market growth can be attributed to the presence of established healthcare infrastructure, high investment in R&D activities, and the increasing prevalence of heart-related health issues. The market in Asia-Pacific is expected to increase at a healthy CAGR during the review period on account of increasing awareness regarding the prevalence of POTS.

    COVID-19 Impact on Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market

    The covid-19 outbreak affected the growth of the postural orthostatic tachycardia syndrome (POTS) treatment market negatively. With the surge in covid-19 cases, healthcare professionals across geographies were emphasizing treating corona-infected patients and other essential healthcare services. Additionally, the number of people visiting hospitals for non-emergency medical issues declined due to fear of infection. This in turn affected the growth of the POTS treatment market.

    Critical Questions Answered in the Report

    • What are the key trends in the global postural orthostatic tachycardia syndrome (POTS) treatment market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on global postural orthostatic tachycardia syndrome (POTS) treatment market?
    • What are the key strategies adopted by the major vendors to lead in the global postural orthostatic tachycardia syndrome (POTS) treatment market?
    • What is the market share of the top vendors?

    Get full scope of the report. Register Here

    Target Audience

    The following is a list of the customers that the Global Postural Orthostatic tachycardia Syndrome market aims to convert the most:

    • Postural orthostatic tachycardia syndrome (POTS) treatment manufacturers
    • Postural orthostatic tachycardia syndrome (POTS) treatment suppliers
    • Postural orthostatic tachycardia syndrome (POTS) treatment distributors
    • Organizations
    • Government bodies

    Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].

    Frequently Asked Questions (FAQs)

    Pfizer Inc. (The U.S), Sanofi S.A. (France), Novartis International AG (Switzerland), The Merck Group (Germany), AstraZeneca plc (UK), Bayer AG (Germany), Daiichi Sankyo Company Limited (Japan), Cigna (The U.S) and HCA International Limited (UK) are among the key players in the Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market.

    North America accounted for the largest share of Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market in 2020.

    The hospitals segment accounted for the largest share of the Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market in 2020.

    The rising awareness among consumers regarding orthostatic intolerance is the prime factor driving the growth of Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market.

    POTS treatment manufacturers, POTS treatment suppliers, POTS treatment distributors, Organizations, Government bodies are the target audience in the Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market.

    •